The US Blood Plasma Derivatives Market is creating new opportunities within the biotechnology and pharmaceutical sectors as demand for specialized biological medicines continues to increase. Market Research Future forecasts the market to reach USD 17.02 billion by 2035, compared with USD 9.79 billion in 2025, reflecting a CAGR of 5.86%. Products derived from human plasma are essential for treating several conditions, including immune deficiencies, hemophilia, and other medical disorders. The increasing demand for effective therapies and growing awareness of their clinical benefits are encouraging healthcare companies to expand their product portfolios.

Innovation and investment are expected to remain important for the industry's long-term development. Companies are exploring improved plasma collection techniques, advanced fractionation processes, and more efficient manufacturing methods. The demand for specialty plasma products is also creating opportunities for pharmaceutical manufacturers to develop targeted treatment solutions. Meanwhile, hospitals, clinics, and medical centers continue to support the adoption of these therapies. With ongoing advancements in medical science and a growing need for specialized treatments, the US blood plasma derivatives industry is positioned for further development.

Q1. What are the major products in the US Blood Plasma Derivatives Market?

The major products include albumin, immunoglobulin, Factor VIII, Factor IX, and hyperimmune globulin.

Q2. Which companies are key participants in this market?

Major companies include Grifols, CSL Behring, Takeda Pharmaceutical Company, Octapharma, Kedrion Biopharma, and Bio Products Laboratory.

Q3. What is the expected market size in 2035?

The market is projected to reach USD 17.02 billion by 2035.

Q4. Why is demand for specialty plasma products increasing?

Growing awareness of targeted therapies and the need to treat specific medical conditions are supporting demand.

Q5. What is the long-term outlook for this industry?

The industry is expected to experience continued growth through technological innovation, rising therapeutic demand, and improvements in plasma collection and processing.

Understand industry shifts with well-researched analysis:

UK ENT Devices Market Trends

South Korea Immunoassay Market Growth

China Leigh Syndrome Treatment Market Demand

GCC Healthcare Consulting Services Market Volume

Italy Stoma Ostomy Care Market Forecast